News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
196,790 Results
Type
Article (18847)
Company Profile (128)
Press Release (177791)
Multimedia
Podcasts (79)
Webinars (15)
Section
Business (58833)
Career Advice (963)
Deals (9561)
Drug Delivery (52)
Drug Development (23834)
Employer Resources (73)
FDA (2525)
Job Trends (4352)
News (93470)
Policy (5879)
Tag
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (503)
Accelerated approval (20)
Adcomms (16)
Allergies (55)
Alliances (16315)
ALS (94)
Alzheimer's disease (650)
Antibody-drug conjugate (ADC) (253)
Approvals (2514)
Artificial intelligence (273)
Autoimmune disease (168)
Automation (18)
Bankruptcy (84)
Best Places to Work (2892)
BIOSECURE Act (20)
Biosimilars (70)
Biotechnology (114)
Bladder cancer (92)
Brain cancer (32)
Breast cancer (273)
Cancer (2383)
Cardiovascular disease (163)
Career advice (802)
Career pathing (29)
CAR-T (213)
CDC (6)
Celiac Disease (1)
Cell therapy (562)
Cervical cancer (14)
Clinical research (21013)
Collaboration (1103)
Company closure (6)
Compensation (369)
Complete response letters (48)
COVID-19 (793)
CRISPR (48)
C-suite (674)
Cystic fibrosis (67)
Data (3035)
Denatured (17)
Depression (56)
Dermatology (30)
Diabetes (159)
Diagnostics (1203)
Digital health (8)
Diversity (3)
Diversity, equity & inclusion (21)
Drug discovery (197)
Drug pricing (53)
Drug shortages (3)
Duchenne muscular dystrophy (137)
Earnings (17654)
Editorial (35)
Employer branding (8)
Employer resources (74)
Events (34381)
Executive appointments (601)
FDA (3626)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (24)
Funding (894)
Gene editing (126)
Generative AI (34)
Gene therapy (449)
GLP-1 (414)
Government (749)
Grass and pollen (1)
Guidances (92)
Healthcare (2440)
HIV (16)
Huntington's disease (42)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (58)
Immunology and inflammation (204)
Immuno-oncology (56)
Indications (53)
Infectious disease (929)
Inflammatory bowel disease (119)
Inflation Reduction Act (3)
Influenza (57)
Intellectual property (119)
Interviews (145)
IPO (4196)
IRA (14)
Job creations (1484)
Job search strategy (710)
JPM (46)
Kidney cancer (8)
Labor market (70)
Layoffs (260)
Leadership (31)
Legal (1218)
Liver cancer (26)
Longevity (15)
Lung cancer (270)
Lymphoma (203)
Machine learning (30)
Management (24)
Manufacturing (499)
MASH (64)
Medical device (709)
Medtech (715)
Mergers & acquisitions (5851)
Metabolic disorders (560)
mRNA (108)
Multiple sclerosis (82)
NASH (8)
Neurodegenerative disease (217)
Neuropsychiatric disorders (51)
Neuroscience (1317)
Neurotech (1)
NextGen: Class of 2026 (1462)
Non-profit (467)
Now hiring (51)
Obesity (307)
Opinion (213)
Ovarian cancer (100)
Pain (78)
Pancreatic cancer (115)
Parkinson's disease (170)
Partnered (16)
Patents (226)
Patient recruitment (264)
Peanut (19)
People (23547)
Pharmaceutical (16)
Phase 1 (8102)
Phase 2 (10041)
Phase 3 (5635)
Pipeline (3086)
Policy (146)
Postmarket research (307)
Preclinical (3350)
Press Release (61)
Prostate cancer (89)
Psychedelics (36)
Radiopharmaceuticals (116)
Rare diseases (526)
Real estate (2472)
Recruiting (41)
Regulatory (5636)
Reports (27)
Research institute (542)
Resumes & cover letters (156)
Rett syndrome (16)
RNA editing (18)
RSV (29)
Schizophrenia (42)
Series A (190)
Series B (122)
Service/supplier (5)
Sickle cell disease (44)
Special edition (20)
Spinal muscular atrophy (59)
Sponsored (17)
Startups (1844)
State (1)
Stomach cancer (7)
Supply chain (41)
Tariffs (40)
The Weekly (61)
Vaccines (383)
Venture capital (103)
Weight loss (183)
Women's health (30)
Worklife (11)
Date
Last 7 days (346)
Last 30 days (1137)
Last 365 days (11948)
2026 (4564)
2025 (11897)
2024 (12642)
2023 (13200)
2022 (16037)
2021 (16923)
2020 (13174)
2019 (9492)
2018 (7536)
2017 (8975)
2016 (8112)
2015 (9408)
2014 (9724)
2013 (9447)
2012 (6079)
2011 (6451)
2010 (5840)
Location
Africa (334)
Alabama (60)
Alaska (3)
Arizona (78)
Arkansas (3)
Asia (14421)
Australia (2831)
California (5008)
Canada (1361)
China (597)
Colorado (110)
Connecticut (181)
Delaware (121)
Europe (32367)
Florida (628)
Georgia (78)
Hawaii (2)
Idaho (14)
Illinois (244)
India (37)
Indiana (257)
Iowa (7)
Japan (219)
Kansas (25)
Kentucky (9)
Louisiana (6)
Maine (2)
Maryland (631)
Massachusetts (3949)
Michigan (120)
Minnesota (226)
Mississippi (1)
Missouri (35)
Montana (12)
Nebraska (5)
Nevada (43)
New Hampshire (10)
New Jersey (1101)
New Mexico (11)
New York (1182)
North Carolina (681)
North Dakota (6)
Northern California (2467)
Ohio (115)
Oklahoma (11)
Oregon (11)
Pennsylvania (945)
Puerto Rico (12)
Rhode Island (19)
South America (406)
South Carolina (10)
Southern California (2006)
Tennessee (34)
Texas (710)
United States (16526)
Utah (71)
Virginia (45)
Washington D.C. (24)
Washington State (601)
West Virginia (1)
Wisconsin (36)
196,790 Results for "moleculin biotech".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Moleculin Biotech Secures Strategic Additional Patent, Strengthening Global Positioning of Annamycin
May 8, 2026
·
5 min read
Press Releases
Moleculin’s Annamycin Extends Survival by More Than 60% in Metastatic Pancreatic Cancer Preclinical Models - Data Presented at AACR 2026
April 23, 2026
·
7 min read
Press Releases
Moleculin Announces Abstract Accepted for Poster Presentation at the 2026 ASCO Annual Meeting
April 21, 2026
·
5 min read
Press Releases
Moleculin to Present at 38th Annual ROTH Conference
March 17, 2026
·
2 min read
Press Releases
Moleculin Releases Next CEO Corner Segment Highlighting Annamycin’s Non-Cardiotoxic Profile
April 7, 2026
·
4 min read
Press Releases
Moleculin Releases Next CEO Corner Segment Highlighting MIRACLE Study
March 11, 2026
·
4 min read
Press Releases
Moleculin Announces Notice of Allowance for Japanese Patent Covering Annamycin
February 17, 2026
·
5 min read
Press Releases
Moleculin Launches CEO Corner Platform to Share Strategic Insights
February 13, 2026
·
4 min read
Press Releases
Moleculin Announces Exercise of Warrants for $8.3 Million Gross Proceeds
February 19, 2026
·
5 min read
Company closure
6 biotechs that called it quits in Q1
Six biotechs based in California, Massachusetts, Washington and Denmark had to halt drug development efforts this year. One of their CEOs is now in an interim chief executive role at another biotech.
April 30, 2026
·
6 min read
·
Angela Gabriel
1 of 19,679
Next
